Yonsei University: Carcinoma trials

The registry lists 22 Carcinoma studies with Yonsei University as lead sponsor. 7 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 13Phase 3 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• JIN-A02 Plus Amivantamab in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI FailureNot yet recruitingNCT07798921Phase 1
• A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)RecruitingNCT07252323Not applicable
• A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT07246668Phase 2
• Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular CarcinomaRecruitingNCT06595108Not applicable
• First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial CancerRecruitingNCT06502743Phase 2
• Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular CarcinomaNot yet recruitingNCT05908916Phase 2
• The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN TrialRecruitingNCT05753839Not applicable
• Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma (ACTS-29)CompletedNCT02844075Phase 2Results posted
• Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib TreatmentCompletedNCT05517239Phase 2
• Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular CarcinomaStatus unknownNCT05173610Phase 2
• Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the EsophagusStatus unknownNCT03785496Phase 2
• Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver TransplantationCompletedNCT03490461
• Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular CarcinomaCompletedNCT02425605Phase 2
• A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of EsophagusStatus unknownNCT02353936Phase 2
• Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional StudyCompletedNCT02188901Not applicable
• An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.Status unknownNCT02145312Phase 2
• A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of EsophagusCompletedNCT01608022Phase 2
• Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and NeckStatus unknownNCT01527877Phase 2
• PF-00299804 in Patients With Head and Neck Squamous Cell CarcinomaCompletedNCT01449201Phase 2
• Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and BiomarkersStatus unknownNCT01336452Not applicable
• Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular CarcinomaStatus unknownNCT01277653
• Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular CarcinomaCompletedNCT01088581Phase 3